LH LABORATORY CORP AMER HLDGS

Ownership history in UBS Group AG  ·  69 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in LABORATORY CORP AMER HLDGS (LH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2016 Q1)
Avg. % of fund
0.01%
First filed
2014 Q4
Last filed
2025 Q4
Quarters held
69
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 495,535 +10,506 +2.2% 0.02% $124.3M $250.25
2025 Q3 ADDED 485,029 +484,829 +242414.5% 0.02% $139.2M $285.58
2025 Q3 REDUCED 200 -497,230 -100.0% 0.00% $57K $285.58
2025 Q2 ADDED 497,430 +497,230 +248615.0% 0.02% $130.6M $260.48
2025 Q2 REDUCED 200 -441,440 -100.0% 0.00% $53K $260.48
2025 Q1 ADDED 441,640 +441,440 +220720.0% 0.02% $102.8M $230.27
2025 Q1 REDUCED 200 -387,522 -99.9% 0.00% $47K $230.27
2024 Q4 ADDED 387,722 +21,398 +5.8% 0.02% $88.9M $226.24
2024 Q3 REDUCED 366,324 -17,675 -4.6% 0.02% $81.9M $219.82
2024 Q2 ADDED 383,999 +368,899 +2443.0% 0.02% $78.1M $199.55
59 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LH price (monthly, adj. close)
← Back to UBS Group AG Holdings